Inhibition of advanced glycation end product formation by Pu-erh Tea ameliorates progression of experimental diabetic nephropathy

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 16, 2012, Pages 4102-4110

  Yan, Shi Jun ^a,b,c   Wang, Lei ^a,b,c   Li, Zhi ^a,b,c   Zhu, Di Na ^a,b,c   Guo, Shao Chen ^a,b,c   Xin, Wen Feng ^a,b,c   Yang, Yan Fang ^a   Cong, Xiao ^a,b,c   Ma, Tao ^d   Shen, Pei Ping ^f   Sheng, Jun ^e,f   Zhang, Wen Sheng ^a,b,c,f  

^a BEIJING NORMAL UNIVERSITY   (China)

^b Beijing Area Major Laboratory of Protection and Utilization of Traditional Chinese Medicine   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^e YUNNAN AGRICULTURAL UNIVERSITY   (China)

^f Beijing pu'Er Tea Research Institute   (China)

Author keywords

advanced glycation end products; db db mice; diabetic nephropathy; glyoxalase I; methylglyoxal; Pu erh tea; RAGE; rosiglitazone

Indexed keywords

ADVANCED GLYCATION END PRODUCTS; DB/DB MOUSE; DIABETIC NEPHROPATHY; GLYOXALASE; METHYLGLYOXAL; PU-ERH TEA; RAGE; ROSIGLITAZONE;

GLUCOSE; MAMMALS;

DISEASES;

ADVANCED GLYCATION END PRODUCT; PLANT EXTRACT;

ANIMAL; ARTICLE; CHEMISTRY; DIABETIC NEPHROPATHY; DISEASE COURSE; DOWN REGULATION; FEMALE; GLOMERULUS; HUMAN; MALE; METABOLISM; MOUSE; PATHOLOGY; TEA;

ANIMALS; CAMELLIA SINENSIS; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KIDNEY GLOMERULUS; MALE; MICE; PLANT EXTRACTS; TEA;

MUS;

EID: 84860324467     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf300347p     Document Type: Article

References (39)

1. Ritz, E.; Rychlik, I.; Locatelli, F.; Halimi, S. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions Am. J. Kidney Dis. 1999, 34 (5) 795-808 (Pubitemid 29521694)
2. Krolewski, M.; Eggers, P. W.; Warram, J. H. Magnitude of end-stage renal disease in IDDM: A 35 year follow-up study Kidney Int. 1996, 50 (6) 2041-6 (Pubitemid 26417548)
3. Mogensen, C. E. Renal function changes in diabetes Diabetes 1976, 25 (Suppl. 2) 872-9
4. Jones, R. H.; Hayakawa, H.; Mackay, J. D.; Parsons, V.; Watkins, P. J. Progression of diabetic nephropathy Lancet 1979, 1 (8126) 1105-6 (Pubitemid 9184867)
5. Kodama, H.; Fujita, M.; Yamaguchi, I. Development of hyperglycaemia and insulin resistance in conscious genetically diabetic (C57BL/KsJ-db/db) mice Diabetologia 1994, 37 (8) 739-44 (Pubitemid 24247843)
6. Sharma, K.; McCue, P.; Dunn, S. R. Diabetic kidney disease in the db/db mouse Am. J. Physiol. Renal Physiol. 2003, 284 (6) F1138-44
7. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications Nature 2001, 414 (6865) 813-20 (Pubitemid 34000785)
8. Suzuki, D.; Miyata, T. Carbonyl stress in the pathogenesis of diabetic nephropathy Intern Med. (Tokyo) 1999, 38 (4) 309-14
9. Schmidt, A. M.; Yan, S. D.; Wautier, J. L.; Stern, D. Activation of receptor for advanced glycation end products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis Circ. Res. 1999, 84 (5) 489-97 (Pubitemid 29138585)
10. Schmidt, A. M.; Yan, S. D.; Yan, S. F.; Stern, D. M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J. Clin. Invest. 2001, 108 (7) 949-55 (Pubitemid 32946067)
11. Brownlee, M.; Cerami, A.; Vlassara, H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications N. Engl. J. Med. 1988, 318 (20) 1315-21
12. Totlani, V. M.; Peterson, D. G. Epicatechin carbonyl-trapping reactions in aqueous maillard systems: Identification and structural elucidation J. Agric. Food Chem. 2006, 54 (19) 7311-8 (Pubitemid 44554957)
13. Kato, A.; Minoshima, Y.; Yamamoto, J.; Adachi, I.; Watson, A. A.; Nash, R. J. Protective effects of dietary chamomile tea on diabetic complications J. Agric. Food Chem. 2008, 56 (17) 8206-11
14. Yokozawa, T.; Nakagawa, T.; Oya, T.; Okubo, T.; Juneja, L. R. Green tea polyphenols and dietary fibre protect against kidney damage in rats with diabetic nephropathy J. Pharm. Pharmacol. 2005, 57 (6) 773-80 (Pubitemid 40694886)
15. Ribaldo, P. D.; Souza, D. S.; Biswas, S. K.; Block, K.; Lopes, D. F. J.; Lopes, D. F. J. Green tea (Camellia sinensis) attenuates nephropathy by downregulating Nox4 NADPH oxidase in diabetic spontaneously hypertensive rats J. Nutr. 2009, 139 (1) 96-100
16. Gong, J.; Peng, C.; Chen, T.; Gao, B.; Zhou, H. Effects of theabrownin from pu-erh tea on the metabolism of serum lipids in rats: mechanism of action J. Food Sci. 2010, 75 (6) H182-9
17. Cao, Z. H.; Gu, D. H.; Lin, Q. Y.; Xu, Z. Q.; Huang, Q. C.; Rao, H.; Liu, E. W.; Jia, J. J.; Ge, C. R. Effect of pu-erh tea on body fat and lipid profiles in rats with diet-induced obesity Phytother. Res. 2011, 25 (2) 234-8
18. Hou, Y.; Shao, W.; Xiao, R.; Xu, K.; Ma, Z.; Johnstone, B. H.; Du, Y. Pu-erh tea aqueous extracts lower atherosclerotic risk factors in a rat hyperlipidemia model Exp. Gerontol. 2009, 44 (6-7) 434-9
19. Duh, P. D.; Yen, G. C.; Yen, W. J.; Wang, B. S.; Chang, L. W. Effects of pu-erh tea on oxidative damage and nitric oxide scavenging J. Agric. Food Chem. 2004, 52 (26) 8169-76
20. Wang, D.; Xu, K.; Zhong, Y.; Luo, X.; Xiao, R.; Hou, Y.; Bao, W.; Yang, W.; Yan, H.; Yao, P.; Liu, L. Acute and subchronic oral toxicities of Pu-erh black tea extract in Sprague-Dawley rats J. Ethnopharmacol. 2011, 134 (1) 156-64
21. Rong, J. X.; Qiu, Y.; Hansen, M. K.; Zhu, L.; Zhang, V.; Xie, M.; Okamoto, Y.; Mattie, M. D.; Higashiyama, H.; Asano, S.; Strum, J. C.; Ryan, T. E. Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone Diabetes 2007, 56 (7) 1751-60 (Pubitemid 47025441)
22. Wiggin, T. D.; Kretzler, M.; Pennathur, S.; Sullivan, K. A.; Brosius, F. C.; Feldman, E. L. Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice Endocrinology 2008, 149 (10) 4928-37
23. Dhar, A.; Desai, K.; Liu, J.; Wu, L. Methylglyoxal, protein binding and biological samples: Are we getting the true measure? J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2009, 877 (11-12) 1093-100
24. Chaplen, F. W.; Fahl, W. E.; Cameron, D. C. Method for determination of free intracellular and extracellular methylglyoxal in animal cells grown in culture Anal. Biochem. 1996, 238 (2) 171-8 (Pubitemid 26234878)
25. Ohno, T.; Takemura, G.; Murata, I.; Kagawa, T.; Akao, S.; Minatoguchi, S.; Fujiwara, T.; Fujiwara, H. Water extract of the root of Lindera strychnifolia slows down the progression of diabetic nephropathy in db/db mice Life Sci. 2005, 77 (12) 1391-403 (Pubitemid 40943679)
26. Lee, S. M.; Graham, A. Early immunopathologic events in experimental diabetic nephropathy: A study in db/db mice Exp. Mol. Pathol. 1980, 33 (3) 323-32 (Pubitemid 11205504)
27. Lim, A. K.; Ma, F. Y.; Nikolic-Paterson, D. J.; Kitching, A. R.; Thomas, M. C.; Tesch, G. H. Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury Diabetologia 2010, 53 (8) 1772-82
28. Flyvbjerg, A.; Denner, L.; Schrijvers, B. F.; Tilton, R. G.; Mogensen, T. H.; Paludan, S. R.; Rasch, R. Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice Diabetes 2004, 53 (1) 166-72 (Pubitemid 38044711)
29. Thornalley, P. J. Glyoxalase I-Structure, function and a critical role in the enzymatic defence against glycation Biochem. Soc. Trans. 2003, 31 (Part 6) 1343-8 (Pubitemid 38030973)
30. Lu, M.; Sarruf, D. A.; Talukdar, S.; Sharma, S.; Li, P.; Bandyopadhyay, G.; Nalbandian, S.; Fan, W.; Gayen, J. R.; Mahata, S. K.; Webster, N. J.; Schwartz, M. W.; Olefsky, J. M. Brain PPAR-gamma promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones Nat. Med. 2011, 17 (5) 618-22
31. Ryan, K. K.; Li, B.; Grayson, B. E.; Matter, E. K.; Woods, S. C.; Seeley, R. J. A role for central nervous system PPAR-gamma in the regulation of energy balance Nat. Med. 2011, 17 (5) 623-6
32. Bangstad, H. J.; Osterby, R.; Dahl-Jorgensen, K.; Berg, K. J.; Hartmann, A.; Hanssen, K. F. Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy Diabetologia 1994, 37 (5) 483-90 (Pubitemid 24133651)
33. Brownlee, M.; Vlassara, H.; Kooney, A.; Ulrich, P.; Cerami, A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking Science 1986, 232 (4758) 1629-32 (Pubitemid 16095602)
34. Reiniger, N.; Lau, K.; McCalla, D.; Eby, B.; Cheng, B.; Lu, Y.; Qu, W.; Quadri, N.; Ananthakrishnan, R.; Furmansky, M.; Rosario, R.; Song, F.; Rai, V.; Weinberg, A.; Friedman, R.; Ramasamy, R.; D'Agati, V.; Schmidt, A. M. Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse Diabetes 2010, 59 (8) 2043-54
35. Myint, K. M.; Yamamoto, Y.; Doi, T.; Kato, I.; Harashima, A.; Yonekura, H.; Watanabe, T.; Shinohara, H.; Takeuchi, M.; Tsuneyama, K.; Hashimoto, N.; Asano, M.; Takasawa, S.; Okamoto, H.; Yamamoto, H. RAGE control of diabetic nephropathy in a mouse model: Effects of RAGE gene disruption and administration of low-molecular weight heparin Diabetes 2006, 55 (9) 2510-22 (Pubitemid 44871151)
36. Marx, N.; Walcher, D.; Ivanova, N.; Rautzenberg, K.; Jung, A.; Friedl, R.; Hombach, V.; de Caterina, R.; Basta, G.; Wautier, M. P.; Wautiers, J. L. Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products Diabetes 2004, 53 (10) 2662-8 (Pubitemid 39299276)
37. Singh, R.; Barden, A.; Mori, T.; Beilin, L. Advanced glycation end-products: A review Diabetologia 2001, 44 (2) 129-46 (Pubitemid 32156196)
38. Barati, M. T.; Merchant, M. L.; Kain, A. B.; Jevans, A. W.; McLeish, K. R.; Klein, J. B. Proteomic analysis defines altered cellular redox pathways and advanced glycation end-product metabolism in glomeruli of db/db diabetic mice Am. J. Physiol. Renal Physiol. 2007, 293 (4) F1157-65
39. Kuhla, B.; Boeck, K.; Luth, H. J.; Schmidt, A.; Weigle, B.; Schmitz, M.; Ogunlade, V.; Munch, G.; Arendt, T. Age-dependent changes of glyoxalase I expression in human brain Neurobiol. Aging 2006, 27 (6) 815-22